|
TVTX Travere Therapeutics Inc 1438533 |
| Balance Sheet |
|
Current Assets
|
$392,681,000.00 |
|
Assets
|
$555,188,000.00 |
|
Current Liabilities
|
$125,437,000.00 |
|
Liabilities
|
$456,460,000.00 |
|
Equity
|
$98,728,000.00 |
|
Shares Out
|
92403744.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-40,366,000.00 |
|
Investing Cash Flow
|
$21,549,000.00 |
| Market Analysis |
Market Cap
|
$5,292,886,456.32 |
|
Price
|
$54.27 |
|
BVPS
|
1.07 |
|
PB
|
53.53 |
|
EPS
|
-0.40 |
|
PS
|
10.34 |
|
FCF
|
$-40,741,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:19 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:13 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-19 |
0.37 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-04 |
0.05 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
0.13 |
|
| Oct |
Nov |
Dec |
|
|
2025-10-30 |
0.59 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TVTX documents filed with the SEC.
TVTX Filings
Clear
